| 4.62 Data as of Jun 18 |  +0.095 / +2.10%Today’s Change | 2.07 Today|||52-Week Range 4.78 | +76.37% Year-to-Date |
| Happy Flag Day Jun 14 / StockTwits | Why Avanir Pharmaceuticals Shares Jumped Jun 05 / MotleyFool.com |
| Avanir to Expedite AVP-786 Development - Analyst Blog Jun 06 / Zacks.com |
| Previous close | 4.52 |
| Today’s open | 4.51 |
| Day’s range | -- - -- |
| Volume | 3,017,051 |
| Average volume (3 months) | 1,627,763 |
| Market cap | $655.9M |
| Dividend yield | -- |
| Earnings growth (last year) | +11.76% |
| Earnings growth (this year) | +19.37% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +293.25% |
| P/E ratio | NM |
| Price/Sales | 10.34 |
| Price/Book | 16.74 |
| Today’s change | Today’s % change | |
|---|---|---|
| LGNDLigand Pharmaceutica... | +1.11 | +3.53% |
| MACKMerrimack Pharmaceut... | +0.01 | +0.16% |
| CBPOChina Biologic Produ... | +0.67 | +2.95% |
| OPTROptimer Pharmaceutic... | +0.01 | +0.07% |
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $41.3M |
| Annual profit (last year) | -$59.7M |
| Net profit margin | -144.75% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Keith A. Katkin, MBA, CPA |
Secretary & Vice President-Finance Christine G. Ocampo, CPA |
Corporate headquarters Aliso Viejo, California |
.
